Clinical issue
==============

Tuberous sclerosis complex (TSC) is a multi-organ disease caused by mutations in either of the *TSC1* or *TSC2* genes, the products of which act as repressors of a fundamentally important kinase, mTORC1. Patients with TSC develop hamartomas (benign tumor-like overgrowths of normal mature cells) in the brain, kidney, skin, lung and heart. Brain hamartomas (known as 'tubers') are thought to cause the neurological manifestations of the disease, which include epilepsy, autism, mental retardation and psychiatric problems. Disease prognosis depends on the severity of the symptoms, which range from mild skin abnormalities to severe mental retardation, seizures and kidney failure. There is no cure, although mTORC1 inhibitors are currently being tested in clinical trials as a 'rational' therapeutic. Although mouse and rat models of TSC exist, many fundamental questions regarding the mechanisms of disease initiation and progression remain, particularly with respect to the development of brain tubers.

Results
=======

The authors develop a model system of TSC by introducing a premature stop codon in the zebrafish *tsc2* gene (which encodes the protein tuberin). This *tsc2^vu242^* allele prevents translation of the GTPase-activating protein (GAP) domain of tuberin, which is known to be required for TORC1 inhibition. Zebrafish homozygous for the *tsc2^vu242^* mutation die at larval stages and have increased TORC1 signaling, abnormally large cells in the brain and liver, and forebrain disorganization. Heterozygous *tsc2^vu242^* zebrafish have slight increases in TORC1 signaling but no abnormalities in cell size or tissue organization. Treatment of homozygous *tsc2^vu242^* zebrafish with rapamycin, a potent and specific inhibitor of the TORC1 complex, reverses signaling abnormalities and restores cell size to normal. In transplantation experiments, *tsc2*-deficient cells have increased TORC1 signaling in a cell-autonomous manner, as expected. However, non-cell-autonomous effects are also observed, because mutant cells can recruit wild-type cells to ectopic regions of the host forebrain.

Implications and future directions
==================================

Although the precise roles of *TSC1* and *TSC2* genes during normal development, as well as during hamartoma formation in patients with TSC, remain elusive, it is clear that control of mTORC1 signaling is highly important for many aspects of the disease. This zebrafish model of TSC will enhance understanding of normal tuberin function, and of the cell-autonomous and non-cell-autonomous mechanisms required for the development of hamartomas in patients with TSC. Future approaches using this model system will include investigation of key genetic interactions and screening for compounds that can modulate TOR-dependent and -independent signaling pathways.
